Reynolds Andrew N, Lang Jessica, Brand Amanda, Mann Jim
Edgar Diabetes and Obesity Research Centre (EDOR), University of Otago, Dunedin, New Zealand.
Department of Medicine, University of Otago, Dunedin, New Zealand.
Obes Rev. 2025 Jan;26(1):e13837. doi: 10.1111/obr.13837. Epub 2024 Sep 19.
Some dietary recommendations continue to recommend carbohydrate restriction as a cornerstone of dietary advice for people with diabetes.
We compared the cardiometabolic effects of diets higher in both fiber and carbohydrate with lower carbohydrate lower fiber diets in type 1 or type 2 diabetes.
MEDLINE, Embase, and the Cochrane Database of Systematic Reviews up to June 24, 2024, with additional hand searching.
Randomized controlled trials in which both dietary fiber and carbohydrate amount had been modified were identified from source evidence syntheses on carbohydrate amount in people with diabetes.
Two reviewers independently.
Ten eligible trials including 499 participants with diabetes (98% with T2) were identified from the potentially eligible 828 trials included in existing evidence syntheses. Pooled findings indicate that higher fiber higher carbohydrate diets reduced HbA1c (mean difference [MD] -0.50% [95% confidence interval -0.99 to -0.02]), fasting insulin (MD -0.99 μIU/mL [-1.83 to -0.15]), total cholesterol (MD -0.16 mmol/L [-0.27 to -0.05]) and low-density lipoprotein cholesterol (MD -0.16 mmol/L (-0.31 to -0.01) when compared with lower carbohydrate lower fiber diets. Trials with larger differences in fiber and carbohydrate intakes between interventions reported greater reductions. Certainty of evidence for these outcomes was moderate or high, with most outcomes downgraded due to heterogeneity unexplained by any single variable.
Our predefined scope excluded trials with co-interventions such as energy restriction, which may have provided addition information.
Findings indicate the greater importance of promoting dietary fiber intakes, and the relative unimportance of carbohydrate amount in recommendations for people with diabetes.
一些饮食建议仍将限制碳水化合物摄入作为糖尿病患者饮食建议的基石。
我们比较了高纤维高碳水化合物饮食与低碳水化合物低纤维饮食对1型或2型糖尿病患者心脏代谢的影响。
截至2024年6月24日的MEDLINE、Embase和Cochrane系统评价数据库,并进行了额外的手工检索。
从关于糖尿病患者碳水化合物摄入量的源证据综合分析中确定了膳食纤维和碳水化合物含量均有改变的随机对照试验。
两名评审员独立进行。
从现有证据综合分析中纳入的828项潜在合格试验中,确定了10项合格试验,包括499名糖尿病患者(98%为2型糖尿病)。汇总结果表明,与低碳水化合物低纤维饮食相比,高纤维高碳水化合物饮食可降低糖化血红蛋白(平均差[MD]-0.50%[95%置信区间-0.9至-0.02])、空腹胰岛素(MD-0.99μIU/mL[-1.83至-0.15])、总胆固醇(MD-0.16mmol/L[-0.27至-0.05])和低密度脂蛋白胆固醇(MD-0.16mmol/L[-0.31至-0.01])。干预措施之间膳食纤维和碳水化合物摄入量差异较大的试验报告的降幅更大。这些结果的证据确定性为中等或高,大多数结果由于任何单一变量无法解释的异质性而被降级。
我们预先确定的范围排除了有能量限制等联合干预措施的试验,这些试验可能提供了更多信息。
研究结果表明,在糖尿病患者的饮食建议中,增加膳食纤维摄入量更为重要,而碳水化合物含量相对不那么重要。